Belite Bio Company Insiders
| BLTE Stock | USD 174.61 0.45 0.26% |
Belite Bio employs about 25 people. The company is managed by 5 executives with a total tenure of roughly 59 years, averaging almost 11.0 years of service per executive, having 5.0 employees per reported executive. Evaluation of Belite Bio's management performance can provide insight into the firm performance.
Belite Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.323) %, meaning that it created substantial loss on money invested by shareholders. Belite Bio's management efficiency ratios could be used to measure how well Belite Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of February 13, 2026, Return On Tangible Assets is expected to decline to -0.23. In addition to that, Return On Capital Employed is expected to decline to -0.26. At present, Belite Bio's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 185 K, whereas Other Assets are forecasted to decline to 0.86.As of February 13, 2026, Common Stock Shares Outstanding is expected to decline to about 24.3 M. In addition to that, Net Loss is expected to decline to about (9.1 M)Belite Bio holds a total of 37.51 Million outstanding shares. Belite Bio ADR retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 32.6 M | Current Value 33.2 M | Avarage Shares Outstanding 21.1 M | Quarterly Volatility 9.7 M |
Belite Bio Workforce Comparison
Belite Bio ADR is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,115. Belite Bio maintains roughly 25.0 in number of employees contributing less than 1% to equities under Health Care industry.
Belite Bio ADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Belite Bio ADR Price Series Summation is a cross summation of Belite Bio price series and its benchmark/peer.
Belite Bio Notable Stakeholders
A Belite Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Belite Bio often face trade-offs trying to please all of them. Belite Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Belite Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| ChingChen MSc | VP Operations | Profile | |
| YuHsin MBA | Chairman CEO | Profile | |
| CFA FRM | CFO Director | Profile | |
| MA MD | Chief Board | Profile | |
| Nathan Mata | Chief Officer | Profile |
About Belite Bio Management Performance
The success or failure of an entity such as Belite Bio ADR often depends on how effective the management is. Belite Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Belite management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Belite management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.23) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (0.29) | (0.27) |
Please note, the presentation of Belite Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Belite Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Belite Bio's management manipulating its earnings.
Belite Bio Workforce Analysis
Traditionally, organizations such as Belite Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Belite Bio within its industry.Belite Bio Manpower Efficiency
Return on Belite Bio Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.4M | |
| Net Loss Per Executive | 7.2M | |
| Working Capital Per Employee | 5.6M | |
| Working Capital Per Executive | 28.2M |
Complementary Tools for Belite Stock analysis
When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |